Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2091]
News [6469]
Articles [133]
Editorials [5]
Conferences [171]
elearning [10]
A single fractionated cycle of 225Ac-J591 shows preliminary efficacy on mCRPC...
Dr Jones Nauseef - Weill Cornell Medicine, New York City, USA
A single fractionated cycle of 225Ac-J591 shows preliminary efficacy on mCRPC patients ( Dr Jones Nauseef - Weill Cornell Medicine, New York City, USA )
20 Apr 2023
Test identifies tumour-infiltrating cell densities as prognostic biomarkers...
Dr James Lindsay - Dana Farber Cancer Institute, Boston, USA
Test identifies tumour-infiltrating cell densities as prognostic biomarkers across a pan-cancer cohort ( Dr James Lindsay - Dana Farber Cancer Institute, Boston, USA )
20 Apr 2023
Choosing the right serum and molecular biomarkers in the Philippines
Dr Jose Jasper Andal - St Luke's Medical Center, Manila, Philippines
Choosing the right serum and molecular biomarkers in the Philippines ( Dr Jose Jasper Andal - St Luke's Medical Center, Manila, Philippines )
12 Apr 2023
CodeBreaK 200 shows sotorasib to be a more tolerable treatment option for...
Dr David Waterhouse - Dana-Farber Cancer Institute, Boston, USA
CodeBreaK 200 shows sotorasib to be a more tolerable treatment option for patients with pretreated, KRASG12C-mutated advanced NSCLC ( Dr David Waterhouse - Dana-Farber Cancer Institute, Boston, USA )
6 Apr 2023
Latest treatments in oesophageal cancer
Dr Costas Bizekis - NYU Langone Perlmutter Cancer Center, New York, USA
Latest treatments in oesophageal cancer ( Dr Costas Bizekis - NYU Langone Perlmutter Cancer Center, New York, USA )
5 Apr 2023
Tumour markers and their role in cancer treatment
Dr Jasper Andal - St Luke's Medical Center, Manila, Philippines
Tumour markers and their role in cancer treatment ( Dr Jasper Andal - St Luke's Medical Center, Manila, Philippines )
4 Apr 2023
SOFT study: Clinical relevance of genomic alterations in premenopausal HR+...
Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia
SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer ( Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia )
28 Mar 2023
Precision oncology: Present and future in breast cancer
Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
Precision oncology: Present and future in breast cancer ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )
28 Mar 2023
Bladder sparing: Risk-enabled therapy after initiating neoadjuvant chemo allows...
Dr Daniel Geynisman - Fox Chase Cancer Center, Pennsylvania, USA
Bladder sparing: Risk-enabled therapy after initiating neoadjuvant chemo allows active surveillance of some MIBC ( Dr Daniel Geynisman - Fox Chase Cancer Center, Pennsylvania, USA )
24 Feb 2023
Genomic profiling of penile squamous cell carcinoma reveals major biomarkers...
Prof Andrea Necchi - The Vita-Salute San Raffaele University, Milan, Italy
Genomic profiling of penile squamous cell carcinoma reveals major biomarkers for efficacy of immunotherapy ( Prof Andrea Necchi - The Vita-Salute San Raffaele University, Milan, Italy )
23 Feb 2023
Latest in PARP inhibitors and combination therapies for prostate cancer
Dr Dan George, Prof Noel Clarke, Dr Friederike Schlurmann and Prof Eleni...
Latest in PARP inhibitors and combination therapies for prostate cancer ( Dr Dan George, Prof Noel Clarke, Dr Friederike Schlurmann and Prof Eleni Efstathiou )
19 Feb 2023
ASCO GU 2023: Latest updates in mRCC
Dr Javier Puente, Dr Bernard Escudier, Prof Stéphane Oudard, Prof Viktor...
ASCO GU 2023: Latest updates in mRCC ( Dr Javier Puente, Dr Bernard Escudier, Prof Stéphane Oudard, Prof Viktor Grünwald and Prof Toni Choueiri )
18 Feb 2023

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation